This is a synthetic peptide designed for use in combination with anti-PLD2 antibody (Catalog #: ARP38182_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-14 AF033850.1 61-74 15-614 BC015033.1 1-600 615-1279 BC056871.1 549-1213 1280-1830 BC015033.1 1266-1816 1831-1995 BC056871.1 1765-1929 1996-3489 BC015033.1 1982-3475
Alias Symbols: -
Protein Interaction Partner: EGFR,PLCG1,ACTB,ACTN1,ALDOA,ALDOC,AMPH,AQP3,ARF1,BIN1,CAV1,CSK,DPYSL2,EGFR,FYN,GAPDH,GM2A,LCK,MTOR,OPRM1,PEA15,PIP5K1A,PLCG1,PRKCA,PRKCD,RPTOR,STXBP1,ALDOA,AMPH,AQP3,ARF1,Actb,BIN1,CAV1,CAV2,EGFR,GAPDH,MTOR,OPRM1,PEA15,PLCG1,PRKCA,PRKCD,RPTOR,SRC